Home > Analysis > Pfizer Inc. (PFE)
Pfizer Inc. (PFE) Share Price
Pfizer Inc. (PFE) Share Price Analysis

Name: Pfizer Inc. (PFE)

Description: Pfizer was at the heart of covid vaccination programs but that hasn't been refelcted in the share price, which has fallen almost -42.0% YTD. Last time out Pfizer beat earnings estimates but took a $5.60 billion write down against falling COVID 19 drug demand. Hopes now rest on anti-obesity treatment Danuglipron, which is midway through FDA trials. 20/11/23


The current Pfizer Inc. (PFE) stock price is $28.91 which is a change of -1.56 or -5.12% from the last closing price of 28.91 with 103,624,040 shares traded giving NYSE:PFE a market capitalisation of $163,237,770,058. The most recent daily high has been 29.4 and daily low 28.3. The NYSE:PFE share price 52 week high has been 54.93 and the 52 week low 28.3. Based on the most recent NYSE:PFE share price opening of 28.91, the current NYSE:PFE EPS (earnings per share) are 1.82 and the PE (price earnings ratio) is 15.86. Pricing data last updated 01/12/2023 16:00.


  • Quarterly loss smaller than forecast
  • Implementing $3.50 billion in cost cuts
  • New respiratory treatment Abrysvo selling well.


  • Sales of antiviral drug Paxlovid have collapsed 97%
  • Q3 revenue down -42% YoY
  • Vulnerable to Medicare price negotiations
  • Outlook
Scroll to Top